Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity.

about

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity.

Item

http://www.wikidata.org/entity/Q47908872

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@en

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@nl

type

Item

label

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@en

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@nl

prefLabel

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@en

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@nl

P1476

Radiosensitisation in vivo by ...... mal tissue radiation toxicity.

@en

P2093

Anne E Kiltie

http://www.w3.org/2001/XMLSchema#string

Blaz Groselj

http://www.w3.org/2001/XMLSchema#string

Ester M Hammond

http://www.w3.org/2001/XMLSchema#string

Helen Scott

http://www.w3.org/2001/XMLSchema#string

Jacqueline Kelly

http://www.w3.org/2001/XMLSchema#string

James Thompson

http://www.w3.org/2001/XMLSchema#string

Jessica Gorrill

http://www.w3.org/2001/XMLSchema#string

Jia-Ling Ruan

http://www.w3.org/2001/XMLSchema#string

Judith Nicholson

http://www.w3.org/2001/XMLSchema#string

Martin Kerr

http://www.w3.org/2001/XMLSchema#string

P2860

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair

Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group

Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach

Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies.

Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy

Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo

Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.

Deoxycytidine kinase expression underpins response to gemcitabine in bladder cancer.

Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies.

P304

381-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-17-0011

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Selvakumar Anbalagan

Cheryl Scudamore

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28839000

http://www.w3.org/2001/XMLSchema#string

P932

5712223

http://www.w3.org/2001/XMLSchema#string